会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Hepatitis C inhibitor tri-peptides
    • 丙型肝炎抑制剂三肽
    • US06642204B2
    • 2003-11-04
    • US10353589
    • 2003-01-29
    • Montse Llinas-BrunetVida J. Gorys
    • Montse Llinas-BrunetVida J. Gorys
    • A61K3806
    • C07K5/0808A61K38/00C07K5/0812C07K5/0827
    • Disclosed herein are compounds of formula (1): wherein R1 is hydroxy or NHSO2R1A wherein R1A is (C1-8)alkyl, (C3-7)cycloalkyl or {(C1-6)alkyl-(C3-7)cycloalkyl}, which are all optionally substituted from 1 to 3 times with halo, cyano, nitro, O—(C1-6)alkyl, amido, amino or phenyl, or R1A is C6 or C10 aryl which is optionally substituted from 1 to 3 times with halo, cyano, nitro, (C1-6)alkyl, O—(C1-6) alkyl, amido, amino or phenyl; R2 is (C4-6)cycloalkyl; R3 is t-butyl or (C5-6) cycloalkyl and R4 is (C4-6)cycloalkyl; or a pharmaceutically acceptable salt thereof. The compounds are useful as inhibitors of HCV NS3 protease.
    • 本文公开的是式(1)的化合物:其中R 1是羟基或NHSO 2 R 1A,其中R 1A是(C 1-8)烷基,(C 3-7)环烷基或{(C 1-6)烷基 - (C 3-7)环烷基},它们都可以任选被卤素,氰基,硝基,O-(C 1-6)烷基,酰胺基,氨基或苯基取代1至3倍,或者R 1A是C 6或C 10芳基 氰基,硝基,(C 1-6)烷基,O-(C 1-6)烷基,酰胺基,氨基或苯基任选被1-3个取代; R 2是(C 4-6)环烷基; R 3是叔丁基或(C 5-6)环烷基,R 4是(C 4-6)环烷基; 或其药学上可接受的盐。 该化合物可用作HCV NS3蛋白酶的抑制剂。